CXCL3 and hepatocellular carcinoma: A similar feedback loop between the MAPK pathway and CD133 expression, which directly affects self-renewal and tumorigenesis, has been described in hepatocellular carcinoma cell lines treated with C-X-C motif chemokine ligand (CXCL)3 [383].